Scarica l'app Stockscreener
0.2666
2.67%
-0.0073
Precedente Chiudi:
$0.2739
Aprire:
$0.28
Volume 24 ore:
361.40K
Relative Volume:
0.05
Capitalizzazione di mercato:
$7.55M
Reddito:
$9.37M
Utile/perdita netta:
$-8.45M
Rapporto P/E:
-0.3291
EPS:
-0.81
Flusso di cassa netto:
$-7.27M
1 W Prestazione:
-8.01%
1M Prestazione:
-13.10%
6M Prestazione:
-66.68%
1 anno Prestazione:
-84.50%
Intervallo 1D:
$0.26
$0.28
Intervallo di 1 settimana:
$0.26
$0.2971
Portata 52W:
$0.1639
$2.2592
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Confronta BIAF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.2654 | 7.94M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
484.96 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
208.32 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
661.58 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.64 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
189.70 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
Navigating Dilution and Growth: bioAffinity Technologies' Warrant Strategy in the Biotech Landscape - AInvest
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds - Business Wire
D-Wave Quantum vs. IonQ: Which is the Better Quantum Computing Stock? - The Globe and Mail
AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun - The Globe and Mail
Can bioAffinity Technologies Inc. Equity Warrant maintain its current growth rateLow Price High Return Opportunities - mustnews.co.kr
Can bioAffinity Technologies Inc. be recession proofSuper Growth Stock Predictions - sisaissue.com
Published on: 2025-08-08 17:01:07 - beatles.ru
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer - The Globe and Mail
Published on: 2025-08-04 09:31:00 - beatles.ru
What are bioAffinity Technologies Inc. Equity Warrant company’s key revenue driversGet high-impact stock recommendations now - Jammu Links News
How strong is bioAffinity Technologies Inc. Equity Warrant company’s balance sheetMarket-crushing profits - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. Equity Warrant stockCapitalize on strategic market trends - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a growth stock or a value stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
bioAffinity Technologies Inc. Stock Analysis and ForecastAchieve rapid financial growth with expert picks - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant stock overvalued or undervaluedFree Market Dynamics Reports - Jammu Links News
How volatile is bioAffinity Technologies Inc. stock compared to the marketFree Market Dynamics Reports - Jammu Links News
What analysts say about bioAffinity Technologies Inc. stockFree Predictions - Jammu Links News
What makes bioAffinity Technologies Inc. stock price move sharplyUnlock powerful insights from market experts - Jammu Links News
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higher in 2025Tremendous growth opportunities - Jammu Links News
Published on: 2025-08-03 18:51:54 - Jammu Links News
How does bioAffinity Technologies Inc. Equity Warrant compare to its industry peersBuild a winning investment strategy - Jammu Links News
What are bioAffinity Technologies Inc. company’s key revenue driversPhenomenal capital appreciation - Jammu Links News
Should I hold or sell bioAffinity Technologies Inc. Equity Warrant stock in 2025Achieve breakthrough investment performance - Jammu Links News
Why is bioAffinity Technologies Inc. Equity Warrant stock attracting strong analyst attentionUnprecedented profits - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc.Discover the fastest growing stocks today - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc. Equity WarrantNavigate market shifts with confidence - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. stockLightning-fast growth - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentMarket-crushing profits - Jammu Links News
Why is bioAffinity Technologies Inc. stock attracting strong analyst attentionCapitalize on emerging trends for profits - Jammu Links News
bioAffinity’s CyPath® Lung Test Detects Early Cancer - MSN
Price Consolidation Hints at Upcoming Move in bioAffinity Technologies Inc. Equity WarrantIntraday Trend Analysis for Fast Gains Released - metal.it
bioAffinity Technologies' CyPath Lung Test Detects Early Cancer with High Accuracy - AInvest
What is bioAffinity Technologies Inc. Equity Warrant company’s growth strategySwing Trade Growth Plan With High Returns - Jammu Links News
Annaly Capital to Issue Series J Preferred; Redeemable 2030 | BIAFW SEC FilingForm 8-K - Stock Titan
Building trade automation scripts for bioAffinity Technologies Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
How Resilient Is bioAffinity Technologies Inc. Stock During Economic DownturnsWeekly Stock Opportunity Radar Scanner Activated - metal.it
Revolutionary CyPath Lung Test Catches Hidden Cancer After Standard Tests Failed: Critical Case Study Reveals - Stock Titan
Published on: 2025-07-28 23:30:16 - metal.it
bioAffinity Technologies Inc. Pullback Analyzed — Is It Time to ExitCommunity Entry Consensus Trade Ideas Shared - metal.it
How many analysts rate bioAffinity Technologies Inc. Equity Warrant as a “Buy”Identify winners with top-tier analysis - Jammu Links News
Technical Models Detect Momentum Build in bioAffinity Technologies Inc. Equity WarrantTarget Return Focused Trade Insights Shared - metal.it
Is bioAffinity Technologies Inc. stock entering bullish territory Free Smart Trend Trading with Weekly Signals - metal.it
What institutional investors are buying bioAffinity Technologies Inc. Equity Warrant stockHigh-profit trading signals - jammulinksnews.com
Is bioAffinity Technologies Inc. a growth stock or a value stockInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in bioAffinity Technologies Inc. stockCapitalize on market trends before they peak - Jammu Links News
What is bioAffinity Technologies Inc. company’s growth strategyInvest confidently with real-time data analysis - Jammu Links News
Is it the right time to buy bioAffinity Technologies Inc. Equity Warrant stockTurn market volatility into profit opportunities - Jammu Links News
What catalysts could drive bioAffinity Technologies Inc. stock higher in 2025Invest smarter with expert stock recommendations - Jammu Links News
What is the risk reward ratio of investing in bioAffinity Technologies Inc. Equity Warrant stockFree Trading Psychology Coaching - jammulinksnews.com
Published on: 2025-07-28 05:02:09 - jammulinksnews.com
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.03%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):